From the *The Russell H. Morgan Department of Radiology and Radiological Science, and †The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.
Clin Nucl Med. 2017 Oct;42(10):e441-e443. doi: 10.1097/RLU.0000000000001785.
Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen-targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.
多参数 MRI（mpMRI）目前是用于成像骨盆内前列腺癌部位的首选检查方法。然而，与前列腺特异性膜抗原结合的 PET 放射性示踪剂的分子成像也越来越多地用于此目的，并且可以补充 mpMRI 的发现。我们报告了一例 59 岁男性，前列腺切除术后血清前列腺特异性抗原水平升高，mpMRI 和前列腺特异性膜抗原靶向 PET 均显示在近端尿道的海绵体部有残留的前列腺癌。
